As the leader of TRANSFERRA’s R&D team, Dr. Maurer provides a unique combination of experience in lipid nanoparticle formulation of small molecules, nucleotide-based drugs, peptides and proteins as preclinical drug candidates. He is also experienced in the application of polymer-based formulations and conventional surfactant and cyclodextrin-based formulations.
Prior to joining TRANSFERRA (formerly Northern Lipids Inc.) in 2015 Dr. Maurer most recently served for eight years as the Head, Formulation/Drug Delivery Division at the Centre for Drug Research and Development in Vancouver Canada. He has designed, set-up, and operated 3 state-of-the-art formulation and drug delivery laboratories; led cross-functional teams in corporate partnerships; and raised funds for drug development in private ventures.
Dr. Maurer received his doctorate in Chemistry from Karl-Franzens University in Austria. He is the author of 31 peer-reviewed publications and an inventor on 6 patents.